Simultaneous occurrence of hypertrophic obstructive cardiomyopathy and long-QT syndrome: A potentially malignant association;Gleichzeitiges vorliegen einer hypertrophisch-obstruktiven kardiomyopathie sowie eines long-QT-syndroms: Eine potentiell maligne assoziation

Zeitschrift fur Kardiologie

Volumn 91, Issue 7, 2002, Pages 575-580

  Meyer zu Vilsendorf, D ^a   Strunk Mueller, C ^a   Gietzen, F H ^a   Kuhn, H ^a  

^a OWL University   (Germany)

Author keywords

Hypertrophic obstructive cardiomyopathy; Long QT syndrome; Prophylactic ICD implantation; Sudden cardiac death

Indexed keywords

ARTICLE; CASE REPORT; CLINICAL EXAMINATION; COMORBIDITY; DEFIBRILLATOR; ELECTROCARDIOGRAM; FEMALE; HEART VENTRICLE FIBRILLATION; HUMAN; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; LONG QT SYNDROME; SUDDEN DEATH; ADULT; CHROMOSOME ABERRATION; CHRONIC BRAIN DISEASE; DOMINANT GENE; ECHOCARDIOGRAPHY; FOLLOW UP; GENETICS; HYPERTROPHIC CARDIOMYOPATHY; PEDIGREE; RESUSCITATION; RISK FACTOR;

ADULT; BRAIN DAMAGE, CHRONIC; CARDIOMYOPATHY, HYPERTROPHIC; CASE REPORT; CHROMOSOME ABERRATIONS; COMORBIDITY; DEATH, SUDDEN, CARDIAC; ECHOCARDIOGRAPHY; ENGLISH ABSTRACT; FEMALE; FOLLOW-UP STUDIES; GENES, DOMINANT; HUMAN; LONG QT SYNDROME; PEDIGREE; RESUSCITATION; RISK FACTORS; HUMANS;

EID: 0036071031     PISSN: 03005860     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00392-002-0811-5     Document Type: Article

References (26)

1. ECG T-wave patterns in genetically distinct forms of the hereditary long QT syndrome
2. Prognostic value of non-sustained ventricular tachycardia and the potential role of amiodarone treatment in hypertrophic cardiomyopathy: Assessment in an unselected non-referral based patient population
3. Prognostic determinants in hypertrophic cardiomyopathy. Prospective evaluation of a therapeutic strategy based on clinical, Holter, hemodynamic, and electrophysiological findings
4. The prognostic significance of nonsustained ventricular tachycardia in hypertrophic cardiomyopathy
5. Risk assessment and prevention of sudden cardiac death in hypertrophic cardiomyopathy
6. Identification of patients with hypertrophic cardiomyopathy at high risk for sudden death
7. Risk stratification in hypertrophic cardiomyopathy
8. Impact of atrial fibrillation on the clinical course of hypertrophic cardiomyopathy
9. Ventricular fibrillation induced by rapid atrial rates in patients with hypertrophic cardiomyopathy
10. The future in hypertrophic cardiomyopathy: Important clues and potential advances from an understanding of the genotype phenotype relationship
11. Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy
12. Long QT syndrome patients with mutations of the SCN5A and HERG genes have differential responses to Na+ channel blockade and to increases in heart rate. Implications for gene-specific therapy
13. Sudden death in hypertrophic cardiomyopathy: Identification of high risk patients
14. Management of patients with the hereditary long QT syndrome
15. Influence of genotype on the clinical course of the long-QT syndrome
16. Erstmitteilung über eine familie mit hypertrophischer kardiomyopathie und long-QT-syndrom
17. Familial hypertrophic cardiomyopathy associated with prolongation of the QT interval
18. QT-interval variability in hypertrophic cardiomyopathy patients with cardiac arrest
19. Ambulatory assessment of the QT interval in patients with hypertrophic cardiomyopathy: Risk stratification and effect of low dose amiodarone
20. Prolonged QT and hypertrophic cardiomyopathy in two families with 10 sudden deaths
21. Prolonged QT interval in hypertrophic and dilated cardiomyopathy in children
22. Diagnostic criteria for the long QT syndrome. An update
23. Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy
24. Indications for implantable cardioverter defibrillator (ICD) therapy
25. Sex differences in cardiac arrest survivors
26. Age- and sex-related differences in clinical manifestations in patients with congenital long-QT syndrome: Findings from the International LQTS Registry